Myelodysplastic syndromes Trials in Duarte, United States
Conditions / Myelodysplastic syndromes / Duarte, United States
Myelodysplastic syndromes is a medical condition with active clinical research programs worldwide.
56 total trials for this combination
Showing top 10 of 56 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00023530 | Blood and Marrow Transplant Clinical Research Network | COMPLETED | NA |
| NCT04313881 | Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) | TERMINATED | PHASE3 |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT00002742 | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer | COMPLETED | PHASE3 |
| NCT06001385 | HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00782145 | A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families | COMPLETED | PHASE3 |
| NCT03904134 | Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) | COMPLETED | NA |
| NCT00003913 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | COMPLETED | PHASE2 |
| NCT00003593 | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome | COMPLETED | PHASE3 |
| NCT04904588 | HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide | ACTIVE_NOT_RECRUITING | PHASE2 |